Revisiting methotrexate and phototrexate Zinc15 library-based derivatives using deep learning in-silico drug design approach

Introduction: Cancer is the second most prevalent cause of mortality in the world, despite the availability of several medications for cancer treatment. Therefore, the cancer research community emphasized on computational techniques to speed up the discovery of novel anticancer drugs.Methods: In the...

Full description

Bibliographic Details
Main Authors: Farhan Siddique, Ahmar Anwaar, Maryam Bashir, Sumaira Nadeem, Ravi Rawat, Volkan Eyupoglu, Samina Afzal, Mehvish Bibi, Yousef A. Bin Jardan, Mohammed Bourhia
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Chemistry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2024.1380266/full
_version_ 1797254048732151808
author Farhan Siddique
Farhan Siddique
Ahmar Anwaar
Maryam Bashir
Maryam Bashir
Sumaira Nadeem
Ravi Rawat
Volkan Eyupoglu
Samina Afzal
Mehvish Bibi
Yousef A. Bin Jardan
Mohammed Bourhia
author_facet Farhan Siddique
Farhan Siddique
Ahmar Anwaar
Maryam Bashir
Maryam Bashir
Sumaira Nadeem
Ravi Rawat
Volkan Eyupoglu
Samina Afzal
Mehvish Bibi
Yousef A. Bin Jardan
Mohammed Bourhia
author_sort Farhan Siddique
collection DOAJ
description Introduction: Cancer is the second most prevalent cause of mortality in the world, despite the availability of several medications for cancer treatment. Therefore, the cancer research community emphasized on computational techniques to speed up the discovery of novel anticancer drugs.Methods: In the current study, QSAR-based virtual screening was performed on the Zinc15 compound library (271 derivatives of methotrexate (MTX) and phototrexate (PTX)) to predict their inhibitory activity against dihydrofolate reductase (DHFR), a potential anticancer drug target. The deep learning-based ADMET parameters were employed to generate a 2D QSAR model using the multiple linear regression (MPL) methods with Leave-one-out cross-validated (LOO-CV) Q2 and correlation coefficient R2 values as high as 0.77 and 0.81, respectively.Results: From the QSAR model and virtual screening analysis, the top hits (09, 27, 41, 68, 74, 85, 99, 180) exhibited pIC50 ranging from 5.85 to 7.20 with a minimum binding score of -11.6 to -11.0 kcal/mol and were subjected to further investigation. The ADMET attributes using the message-passing neural network (MPNN) model demonstrated the potential of selected hits as an oral medication based on lipophilic profile Log P (0.19-2.69) and bioavailability (76.30% to 78.46%). The clinical toxicity score was 31.24% to 35.30%, with the least toxicity score (8.30%) observed with compound 180. The DFT calculations were carried out to determine the stability, physicochemical parameters and chemical reactivity of selected compounds. The docking results were further validated by 100 ns molecular dynamic simulation analysis.Conclusion: The promising lead compounds found endorsed compared to standard reference drugs MTX and PTX that are best for anticancer activity and can lead to novel therapies after experimental validations. Furthermore, it is suggested to unveil the inhibitory potential of identified hits via in-vitro and in-vivo approaches.
first_indexed 2024-04-24T21:43:46Z
format Article
id doaj.art-82b0e7cf9a8a4a4cbe90a23cb420e3f8
institution Directory Open Access Journal
issn 2296-2646
language English
last_indexed 2024-04-24T21:43:46Z
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Chemistry
spelling doaj.art-82b0e7cf9a8a4a4cbe90a23cb420e3f82024-03-21T05:12:30ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462024-03-011210.3389/fchem.2024.13802661380266Revisiting methotrexate and phototrexate Zinc15 library-based derivatives using deep learning in-silico drug design approachFarhan Siddique0Farhan Siddique1Ahmar Anwaar2Maryam Bashir3Maryam Bashir4Sumaira Nadeem5Ravi Rawat6Volkan Eyupoglu7Samina Afzal8Mehvish Bibi9Yousef A. Bin Jardan10Mohammed Bourhia11School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, ChinaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, PakistanFaculty of Pharmacy, Bahauddin Zakariya University, Multan, PakistanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, PakistanSouthern Punjab Institute of Health Sciences, Multan, PakistanDepartment of Pharmacy, The Women University, Multan, PakistanSchool of Health Sciences & Technology, UPES University, Dehradun, IndiaDepartment of Chemistry, Cankırı Karatekin University, Cankırı, TürkiyeDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, PakistanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, PakistanDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaLaboratory of Biotechnology and Natural Resources Valorization, Faculty of Sciences, Ibn Zohr University, Agadir, MoroccoIntroduction: Cancer is the second most prevalent cause of mortality in the world, despite the availability of several medications for cancer treatment. Therefore, the cancer research community emphasized on computational techniques to speed up the discovery of novel anticancer drugs.Methods: In the current study, QSAR-based virtual screening was performed on the Zinc15 compound library (271 derivatives of methotrexate (MTX) and phototrexate (PTX)) to predict their inhibitory activity against dihydrofolate reductase (DHFR), a potential anticancer drug target. The deep learning-based ADMET parameters were employed to generate a 2D QSAR model using the multiple linear regression (MPL) methods with Leave-one-out cross-validated (LOO-CV) Q2 and correlation coefficient R2 values as high as 0.77 and 0.81, respectively.Results: From the QSAR model and virtual screening analysis, the top hits (09, 27, 41, 68, 74, 85, 99, 180) exhibited pIC50 ranging from 5.85 to 7.20 with a minimum binding score of -11.6 to -11.0 kcal/mol and were subjected to further investigation. The ADMET attributes using the message-passing neural network (MPNN) model demonstrated the potential of selected hits as an oral medication based on lipophilic profile Log P (0.19-2.69) and bioavailability (76.30% to 78.46%). The clinical toxicity score was 31.24% to 35.30%, with the least toxicity score (8.30%) observed with compound 180. The DFT calculations were carried out to determine the stability, physicochemical parameters and chemical reactivity of selected compounds. The docking results were further validated by 100 ns molecular dynamic simulation analysis.Conclusion: The promising lead compounds found endorsed compared to standard reference drugs MTX and PTX that are best for anticancer activity and can lead to novel therapies after experimental validations. Furthermore, it is suggested to unveil the inhibitory potential of identified hits via in-vitro and in-vivo approaches.https://www.frontiersin.org/articles/10.3389/fchem.2024.1380266/fulldeep learningQSARvirtual screeningdensity function theorymolecular dynamicsdihydrofolate reductase
spellingShingle Farhan Siddique
Farhan Siddique
Ahmar Anwaar
Maryam Bashir
Maryam Bashir
Sumaira Nadeem
Ravi Rawat
Volkan Eyupoglu
Samina Afzal
Mehvish Bibi
Yousef A. Bin Jardan
Mohammed Bourhia
Revisiting methotrexate and phototrexate Zinc15 library-based derivatives using deep learning in-silico drug design approach
Frontiers in Chemistry
deep learning
QSAR
virtual screening
density function theory
molecular dynamics
dihydrofolate reductase
title Revisiting methotrexate and phototrexate Zinc15 library-based derivatives using deep learning in-silico drug design approach
title_full Revisiting methotrexate and phototrexate Zinc15 library-based derivatives using deep learning in-silico drug design approach
title_fullStr Revisiting methotrexate and phototrexate Zinc15 library-based derivatives using deep learning in-silico drug design approach
title_full_unstemmed Revisiting methotrexate and phototrexate Zinc15 library-based derivatives using deep learning in-silico drug design approach
title_short Revisiting methotrexate and phototrexate Zinc15 library-based derivatives using deep learning in-silico drug design approach
title_sort revisiting methotrexate and phototrexate zinc15 library based derivatives using deep learning in silico drug design approach
topic deep learning
QSAR
virtual screening
density function theory
molecular dynamics
dihydrofolate reductase
url https://www.frontiersin.org/articles/10.3389/fchem.2024.1380266/full
work_keys_str_mv AT farhansiddique revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT farhansiddique revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT ahmaranwaar revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT maryambashir revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT maryambashir revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT sumairanadeem revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT ravirawat revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT volkaneyupoglu revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT saminaafzal revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT mehvishbibi revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT yousefabinjardan revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach
AT mohammedbourhia revisitingmethotrexateandphototrexatezinc15librarybasedderivativesusingdeeplearninginsilicodrugdesignapproach